BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6872 related articles for article (PubMed ID: 19622552)

  • 1. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
    Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
    Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    Int J Equity Health; 2015 Oct; 14():92. PubMed ID: 26450828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
    O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
    Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting and methodological quality of systematic reviews in the orthopaedic literature.
    Gagnier JJ; Kellam PJ
    J Bone Joint Surg Am; 2013 Jun; 95(11):e771-7. PubMed ID: 23780547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
    Shamseer L; Moher D; Clarke M; Ghersi D; Liberati A; Petticrew M; Shekelle P; Stewart LA;
    BMJ; 2015 Jan; 350():g7647. PubMed ID: 25555855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRISMA harms checklist: improving harms reporting in systematic reviews.
    Zorzela L; Loke YK; Ioannidis JP; Golder S; Santaguida P; Altman DG; Moher D; Vohra S;
    BMJ; 2016 Feb; 352():i157. PubMed ID: 26830668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
    Moher D; Shamseer L; Clarke M; Ghersi D; Liberati A; Petticrew M; Shekelle P; Stewart LA;
    Syst Rev; 2015 Jan; 4(1):1. PubMed ID: 25554246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perception of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement of authors publishing reviews in nursing journals: a cross-sectional online survey.
    Tam WWS; Tang A; Woo B; Goh SYS
    BMJ Open; 2019 Apr; 9(4):e026271. PubMed ID: 31005930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer's disease before and after PRISMA introduction.
    Sun X; Zhou X; Yu Y; Liu H
    BMC Med Res Methodol; 2018 Nov; 18(1):154. PubMed ID: 30497417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AHRQ series on complex intervention systematic reviews-paper 7: PRISMA-CI elaboration and explanation.
    Guise JM; Butler M; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():51-58. PubMed ID: 28720513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 344.